Index of reports
> Life Threatening Events (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Remodulin (Treprostinil Subcutaneous) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Remodulin side effects in 44 year old female
Reported by a physician from United States on 2012-04-30
Patient: 44 year old female, weighing 58.2 kg (128.0 pounds)
Reactions: Right Ventricular Failure, Dehydration, Sepsis, Blood Pressure Decreased, White Blood Cell Count Increased, Infusion Site Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Remodulin
Other drugs received by patient: Revatio; Diuretics (Diuretics)
Possible Remodulin side effects in 76 year old male
Reported by a physician from United States on 2012-03-22
Patient: 76 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Respiratory Failure
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tyvaso
Dosage: 72 mcg (18 mcg, 4 in 1 d) , inhalation
Indication: Pulmonary Arterial Hypertension
Start date: 2012-02-07
Remodulin
Dosage: 31.68 ug/kg (0.022 ug/kg, 1 in 1 min) , subcutaneous
Indication: Pulmonary Arterial Hypertension
Start date: 2011-01-17
Other drugs received by patient: Adcirca; Letairis
|